Alliance Global Partners analyst Aaron Grey downgraded Flora Growth to Neutral from Buy without a price target. The company’s Q2 results were below estimates, as competition in the CBD market continued and Flora exited low-margin sales, the analyst tells investors in a research note. The firm cites uncertainty within the existing business for the downgrade.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGC: